C. Wykoff

发表

Diabetic Retinopathy: A Position Statement by the American Diabetes Association

Jennifer K. Sun, Sharon D. Solomon, E. Chew, 2017, Diabetes Care.

Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration

A. Wahle, U. Schmidt-Erfurth, M. Abràmoff, 2019, Investigative ophthalmology & visual science.

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

C. Wykoff, P. Ratcliffe, C. Pugh, 1999, Nature.

Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema.

P. Campochiaro, C. Wykoff, H. Shapiro, 2014, Ophthalmology.

HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

Charles C Wykoff, Adrian L Harris, A. Harris, 2002, Cancer cell.

Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent Growth*

Charles C. Wykoff, Jeffrey A. Engelman, Michael P. Lisanti, 1997, The Journal of Biological Chemistry.

Risk of bias: why measure it, and how?

Rishi P. Singh, M. Bhandari, S. Sivaprasad, 2021, Eye.

Intraoperative OCT of a full-thickness macular hole before and after internal limiting membrane peeling.

Marco Ruggeri, Stephen R Uhlhorn, Charles C Wykoff, 2010, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data

S. Sadda, C. Wykoff, A. Loewenstein, 2019, Eye.

Pars Plana Vitrectomy versus Scleral Buckle: A Comprehensive Meta-Analysis of 15,947 Eyes.

P. Kertes, C. Wykoff, M. Popovic, 2021, Survey of ophthalmology.

Individualized dosing in wet age-related macular degeneration

C. Wykoff, Geeta A. Lalwani, J. Kitchens, 2014 .

Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.

Donna Richardson, Adrian L Harris, A. Harris, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.

A. Harris, P. Watson, C. Wykoff, 2001, Cancer research.

Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis

S. Sivaprasad, C. Wykoff, C. Cheung, 2022, Eye.

Fovea-sparing rhegmatogenous retinal detachments: impact of clinical factors including time to surgery on visual and anatomic outcomes

C. Wykoff, Irene T Lee, S. Lampen, 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

Treat-and-Extend Versus Alternate Dosing Strategies with Anti-Vascular Endothelial Growth Factor agents to treat Center Involving Diabetic Macular Edema: A Systematic Review and Meta-analysis of 2346 Eyes.

S. Sivaprasad, S. Garg, C. Wykoff, 2022, Survey of ophthalmology.

Aflibercept With or Without Suprachoroidal CLS-TA for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study.

C. Wykoff, T. Ciulla, V. Gonzalez, 2020, Ophthalmology. Retina.

Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema

C. Wykoff, T. Ciulla, V. Gonzalez, 2020 .

Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.

S. Sadda, C. Wykoff, M. Nittala, 2020, JAMA ophthalmology.

Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study

C. Wykoff, D. Boyer, David M. Brown, 2017, British Journal of Ophthalmology.

Outcomes With As-Needed Aflibercept and Macular Laser Following the Phase III VISTA DME Trial: ENDURANCE 12-Month Extension Study.

C. Wykoff, D. Boyer, David M. Brown, 2017, American journal of ophthalmology.

Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema: Subanalysis of the VISTA and VIVID Randomized Clinical Trials

C. Wykoff, J. Korobelnik, R. Vitti, 2017, JAMA ophthalmology.

Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T.

C. Wykoff, S. Hariprasad, 2015, Ophthalmic surgery, lasers & imaging retina.

Relationship Between Retinal Fractal Dimension and Non-perfusion in Diabetic Retinopathy on Ultra-Wide Field Fluorescein Angiography.

S. Sadda, C. Wykoff, A. Fleming, 2019, American journal of ophthalmology.

Lasers for the treatment of intraocular tumors

C. Wykoff, A. Berrocal, T. Murray, 2013, Lasers in Medical Science.

Laser/Light Applications in Ophthalmology: Posterior Segment Applications

C. Wykoff, T. Murray, A. Schefler, 2011 .

Atypical teratoid/rhabdoid tumor arising from the third cranial nerve.

M. Rosenblum, J. Biegel, C. Wykoff, 2008, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants With nAMD and Persistent Retinal Fluid.

C. Wykoff, G. Jaffe, J. Heier, 2022, Ophthalmology.

RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Rishi P. Singh, P. Kaiser, C. Wykoff, 2021, Retina.

Quarterly Anti-Vascular Endothelial Growth Factor Dosing for Neovascular Age-Related Macular Degeneration: Real-World Clinical Outcomes.

C. Wykoff, T. P. Wong, Brenda Zhou, 2019, Ophthalmic surgery, lasers & imaging retina.

Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial.

C. Wykoff, F. Asmus, N. Waheed, 2019, Ophthalmology.

Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial

S. Sadda, C. Wykoff, David M. Brown, 2017, British Journal of Ophthalmology.

Comparison of 25- and 27-gauge Sutureless Cannula-based Intraocular Lens Scleral Fixation Visual Acuity Outcomes and Complication Rates.

C. Wykoff, Ankoor R. Shah, T. P. Wong, 2020, Retina.

Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.

C. Wykoff, David M. Brown, J. Payne, 2017, American journal of ophthalmology.

Photodynamic therapy of bullous central serous chorioretinopathy with subretinal exudate and a tear of the retinal pigment epithelium.

B. Lujan, P. Rosenfeld, C. Wykoff, 2009, Retinal cases & brief reports.

THE TEXAS TACO TECHNIQUE FOR INTERNAL LIMITING MEMBRANE FLAP IN LARGE FULL-THICKNESS MACULAR HOLES: A Short-Term Pilot Study.

C. Wykoff, David M. Brown, Ankoor R. Shah, 2020, Retina.

Retinal non-perfusion in diabetic retinopathy

R. Avery, C. Wykoff, R. Tadayoni, 2022, Eye.

Final Outcomes from the Randomized RECOVERY Trial of Alfibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy.

Justis P. Ehlers, C. Wykoff, M. Nittala, 2022, Ophthalmology. Retina.

Baseline retinal vascular bed area on ultra-wide field fluorescein angiography correlates with the anatomical outcome of diabetic macular oedema to ranibizumab therapy: two-year analysis of the DAVE Study

C. Wykoff, Jano van Hemert, K. Falavarjani, 2022, Eye.

SEVERITY OF DIABETIC MACULAR EDEMA CORRELATES WITH RETINAL VASCULAR BED AREA ON ULTRA-WIDE FIELD FLUORESCEIN ANGIOGRAPHY: DAVE Study.

S. Sadda, C. Wykoff, Jano van Hemert, 2020, Retina.

Supplemental Scleral Buckle for the Management of Rhegmatogenous Retinal Detachment by Pars Plana Vitrectomy: A Meta-Analysis of Randomized Controlled Trials

S. Garg, C. Wykoff, M. Phillips, 2021, Ophthalmologica.

Pars Plana Vitrectomy with and without Supplemental Scleral Buckle for the Repair of Rhegmatogenous Retinal Detachment: A Meta-Analysis.

P. Kertes, C. Wykoff, M. Popovic, 2022, Ophthalmology. Retina.

The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept and Bevacizumab on Intraocular Pressure: A Network Meta-Analysis

M. Bhandari, P. Kaiser, S. Sivaprasad, 2021, Ophthalmology.

Guidelines for patient management: considerations before adoption into practice

M. Bhandari, S. Sivaprasad, S. Garg, 2022, Eye.

The 5 min meta-analysis: understanding how to read and interpret a forest plot

Rishi P. Singh, M. Bhandari, S. Sivaprasad, 2022, Eye.

Cohort studies investigating the effects of exposures: key principles that impact the credibility of the results

M. Bhandari, S. Sivaprasad, S. Garg, 2022, Eye.

Retinal vascular bed area on ultra-wide field fluorescein angiography indicates the severity of diabetic retinopathy

S. Sadda, C. Wykoff, A. Fleming, 2021, British Journal of Ophthalmology.

Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.

K. Ghasemi Falavarjani, S. Sadda, C. Wykoff, 2017, American journal of ophthalmology.

Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results

B. Bruce, C. Wykoff, D. Boyer, 2020, British Journal of Ophthalmology.

Weakly-Supervised Vessel Detection in Ultra-Widefield Fundus Photography via Iterative Multi-Modal Registration and Learning

Ajay E. Kuriyan, Gaurav Sharma, C. Wykoff, 2020, IEEE Transactions on Medical Imaging.

Frequency of Urgent or Emergent Vitreoretinal Surgical Procedures in the United States During the COVID-19 Pandemic.

Shriji N. Patel, Andrew X. Chen, Tapan P. Patel, 2021, JAMA ophthalmology.

Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.

A. Harris, P. Watson, C. Wykoff, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carbonic A nhydrase I X E xpression, a N ovel S urrogate M arker of T umor H ypoxia, I s A ssociated W ith a P oor P rognosis i n Non-Small-Cell L ung C ancer

A. Harris, K. O'Byrne, C. Wykoff, 2003 .

NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY

C. Wykoff, A. Fleming, Jano van Hemert, 2021, Retina.

Distribution of Non-perfusion and Neovascularization on Ultra-Wide Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1.

S. Sadda, C. Wykoff, A. Fleming, 2019, American journal of ophthalmology.

Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.

E. Souied, C. Wykoff, J. Monés, 2019, Ophthalmology.

Thresholds for Initiating Treatment of Eyes with Diabetic Macular Edema and Good Vision: Consideration of DRCR.Net Protocol V Results.

C. Wykoff, 2019, Ophthalmology. Retina.

Outcome in Non-Small Cell Lung Cancer Relates to Angiogenic Pathways and Independently to Poor Expression of Hypoxia-inducible Carbonic Anhydrase-9 Updated Version

A. Harris, C. Wykoff, J. Pastorek, 2001 .

Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling

A. Harris, C. Wykoff, P. Ratcliffe, 2000, Oncogene.

The hypoxia‐regulated transcription factor DEC1 (Stra13, SHARP‐2) and its expression in human tissues and tumours

A. Harris, P. Watson, C. Wykoff, 2004, The Journal of pathology.

Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care

I. Chowers, P. Kaiser, C. Wykoff, 2022, Acta ophthalmologica.

Intravitreal aflibercept for proliferative diabetic retinopathy

C. Wykoff, David M. Brown, 2017, The Lancet.

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

Jordan M. Graff, Michael B. Goldstein, Khoi D. Tran, 2022, The Lancet.

Treatment patterns and outcomes with antivascular endothelial growth factor agents for wet age-related macular degeneration in clinical practice: an analysis of the IRIS Registry.

C. Wykoff, M. Maccumber, A. Sagkriotis, 2021, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration

P. Campochiaro, C. Wykoff, D. Pieramici, 2022, Ophthalmology and Therapy.

Headache or Eye Pain as the Presenting Feature of Uveal Melanoma

C. Wykoff, David M. Brown, T. P. Wong, 2013 .

Two Year SAVE Outcomes: 2.0 mg ranibizumab for recalcitrant neovascular AMD.

C. Wykoff, David M. Brown, T. P. Wong, 2013, Ophthalmology.

Efficacy outcomes of brolucizumab versus aflibercept in neovascular age-related macular degeneration patients with early residual fluid.

Rishi P. Singh, C. Wykoff, A. Koh, 2021, Ophthalmology. Retina.

Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical Trial.

C. Wykoff, N. Waheed, D. Boyer, 2021, JAMA ophthalmology.

Changes in retinal ischaemic index correlate with recalcitrant macular oedema in retinal vein occlusion: WAVE study

S. Sadda, C. Wykoff, Jano van Hemert, 2018, British Journal of Ophthalmology.

Seeing the patient’s perspective: a guide to patient-reported outcome measures and minimal important differences in ophthalmic research

M. Bhandari, P. Kaiser, S. Sivaprasad, 2022, Eye.

CASES IN REFINING MANAGEMENT OF DIABETIC MACULAR EDEMA.

C. Wykoff, B. Kuppermann, N. Holekamp, 2018, Retina.

Effects of Long-Term DME Control With 0.2 µg/Day Fluocinolone Acetonide Implant on Quality of Life: An Exploratory Analysis From the FAME Trial.

D. Grewal, C. Wykoff, M. Singer, 2020, Ophthalmic surgery, lasers & imaging retina.

Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study.

P. Campochiaro, C. Wykoff, Robert N. Johnson, 2014, Ophthalmology.

Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad.

A. Cruess, C. Wykoff, S. Michels, 2016, American journal of ophthalmology.

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.

L. Aiello, N. Bressler, E. Duh, 2018, Ophthalmology.

Scleral Buckling Alone or in Combination with Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment Repair: A Meta-Analysis of 7,212 Eyes

P. Kertes, C. Wykoff, M. Popovic, 2022, Ophthalmologica.

Role of Positioning after Full-Thickness Macular Hole Surgery: A Systematic Review and Meta-Analysis.

M. Bhandari, P. Kaiser, S. Sivaprasad, 2022, Ophthalmology. Retina.

Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema.

C. Wykoff, G. Noronha, David M. Brown, 2018, Ophthalmic surgery, lasers & imaging retina.

A clinician’s guide to network meta-analysis

Rishi P. Singh, M. Bhandari, S. Sivaprasad, 2022, Eye.

Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].

C. Wykoff, P. Ratcliffe, H. Turley, 2004, The Journal of biological chemistry.

OLIVES Dataset: Ophthalmic Labels for Investigating Visual Eye Semantics

C. Wykoff, M. Prabhushankar, Y. Logan, 2022, NeurIPS.

Primary rhegmatogenous retinal detachment repair: evidence supports an individualised approach

H. Flynn, C. Wykoff, R. Adelman, 2015, British Journal of Ophthalmology.

THE ASSOCIATION OF EPIRETINAL MEMBRANE WITH MACULAR HOLE FORMATION AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR

C. Wykoff, James D. Palmer, R. Khurana, 2017, Retina.

The clinician’s guide to interpreting a regression analysis

M. Bhandari, S. Sivaprasad, S. Garg, 2022, Eye.

“Iodine Allergy” and the Use of Povidone Iodine for Endophthalmitis Prophylaxis

Jennifer I. Lim, H. Flynn, C. Wykoff, 2019, Journal of vitreoretinal diseases.

Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.

Jennifer K. Sun, Paolo S. Silva, L. Aiello, 2022, JAMA ophthalmology.

Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.

Jennifer K. Sun, Paolo S. Silva, L. Aiello, 2022, JAMA ophthalmology.

Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration

P. Campochiaro, C. Wykoff, D. Pieramici, 2022, Ophthalmology and Therapy.

Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?

M. Bhandari, S. Sivaprasad, S. Garg, 2022, Eye.

Fovea-sparing retinal detachments: time to surgery and visual outcomes.

H. Flynn, C. Wykoff, S. G. Schwartz, 2010, American journal of ophthalmology.

What is the optimal timing for rhegmatogenous retinal detachment repair?

H. Flynn, C. Wykoff, I. Scott, 2013, JAMA ophthalmology.

THE RIGHT ROUTE CAN MAKE ALL THE DIFFERENCE

C. Wykoff, 2019 .

From Bench to Bedside: Faricimab Enters the Clinic.

C. Wykoff, H. Fine, Cecilia Villanueva Boone, 2022, Ophthalmic surgery, lasers & imaging retina.

Plasma VEGF Concentrations after Intravitreous Anti-VEGF Therapy for Diabetic Macular Edema

L. Aiello, N. Bressler, E. Duh, 2019 .

Impact of Race and Ethnicity on Presentation and Surgical Outcomes of Idiopathic Macular Holes

Sagar B. Patel, C. Wykoff, Sagar B Patel, 2022, Journal of personalized medicine.

When to believe a subgroup analysis: revisiting the 11 criteria

M. Bhandari, S. Sivaprasad, S. Garg, 2022, Eye.

Outcomes and Practice Preferences After Endophthalmitis Following Anti-VEGF Intravitreal Injection

C. Regillo, B. Modjtahedi, C. Wykoff, 2019, Journal of VitreoRetinal Diseases.

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)

C. Regillo, C. Wykoff, Namrata Saroj, 2022, BMJ Open Ophthalmology.

Exploring the angiographic-biologic phenotype in the IMAGINE study: quantitative UWFA and cytokine expression

Joseph R. Abraham, Jamie L. Reese, C. Wykoff, 2021, British Journal of Ophthalmology.

Aqueous Cytokine Expression and Higher-Order OCT Biomarkers: Assessment of the Anatomic-Biologic Bridge in the IMAGINE DME Study.

Joseph R. Abraham, Jamie L. Reese, C. Wykoff, 2020, American journal of ophthalmology.

The HIF pathway: implications for patterns of gene expression in cancer.

A. Harris, C. Wykoff, P. Ratcliffe, 2001, Novartis Foundation symposium.

Exogenous fungal endophthalmitis: microbiology and clinical outcomes.

H. Flynn, C. Wykoff, I. Scott, 2008, Ophthalmology.

Myopic laser in situ keratomileusis in eyes with thick corneas

C. Wykoff, R. Pineda, 2006, Journal of cataract and refractive surgery.

Combining Feature Correspondence With Parametric Chamfer Alignment: Hybrid Two-Stage Registration for Ultra-Widefield Retinal Images

Gaurav Sharma, C. Wykoff, Li Ding, 2021, IEEE Transactions on Biomedical Engineering.

Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials

M. Bhandari, P. Kaiser, S. Sivaprasad, 2022, Eye.

Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis

S. Sivaprasad, C. Wykoff, C. Cheung, 2022, Eye.

The clinician’s guide to randomized trials: interpretation

Rishi P. Singh, M. Bhandari, S. Sivaprasad, 2022, Eye.

Treat‐and‐extend regimens of anti‐vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta‐analysis

P. Kaiser, S. Sivaprasad, S. Garg, 2021, Acta ophthalmologica.

Rationale for American Society of Retina Specialists Best Practice Recommendations for Conducting Vitreoretinal Surgery During the Coronavirus Disease-19 Era

Daniel L. Chao, Theodore Leng, D. Ting, 2020, Journal of vitreoretinal diseases.

Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes.

H. Flynn, A. Pathengay, C. Wykoff, 2012, American journal of ophthalmology.

Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010).

H. Flynn, C. Wykoff, J. Sridhar, 2015, American journal of ophthalmology.

Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002-2009).

H. Flynn, C. Wykoff, W. Shi, 2009, American journal of ophthalmology.

Anti-Vascular Endothelial Growth Factor Agents for Pediatric Retinal Diseases

C. Wykoff, A. Berrocal, S. Houston, 2011, International ophthalmology clinics.

Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes.

C. Wykoff, D. Eliott, S. Charles, 2017, Ophthalmology.

Ophthalmology conferences in the coronavirus disease 2019 era.

C. Wykoff, J. Sridhar, Y. Yonekawa, 2020, Current opinion in ophthalmology.

Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration

P. Kaiser, C. Wykoff, M. Zarbin, 2021, JAMA ophthalmology.

Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics.

P. Rosenfeld, H. Flynn, C. Wykoff, 2011, American journal of ophthalmology.

Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use.

H. Flynn, Dennis P. Han, C. Wykoff, 2011, American journal of ophthalmology.

Suprachoroidally injected pharmacological agents for the treatment of chorio‐retinal diseases: a targeted approach

C. Wykoff, G. Noronha, Z. Habot-Wilner, 2019, Acta ophthalmologica.

ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics

C. Wykoff, David M. Brown, M. Benz, 2016, Retina.

Real-World Trends in Intravitreal Injection Practices among American Retina Specialists.

Daniel L. Chao, Rahul Chaturvedi, C. Wykoff, 2019, Ophthalmology. Retina.

Endophthalmitis after intravitreal injection: prevention and management.

H. Flynn, C. Wykoff, 2011, Retina.

Outcomes of Eyes Undergoing Multiple Surgical Interventions Following Failure of Primary Rhegmatogenous Retinal Detachment Repair.

Sagar B. Patel, C. Wykoff, M. Benz, 2022, Ophthalmology. Retina.

Cooling Anesthesia for Intravitreal Injection: Results of the Prospective Open-Label, Dose-Ranging COOL-1 Trial

Daniel L. Chao, C. Wykoff, A. Khanani, 2021, Clinical ophthalmology.

OPTH_A_336653 4659..4666

Daniel L. Chao, C. Wykoff, A. Khanani, 2021 .

Laser treatment for retinopathy of prematurity

C. Wykoff, A. Berrocal, T. Murray, 2013, Lasers in Medical Science.

Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

P H Watson, A. Harris, P. Watson, 2000, Cancer research.

Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration.

E. Souied, C. Wykoff, A. Lotery, 2020, Ophthalmology.

DEC1 (STRA13) protein expression relates to hypoxia‐ inducible factor 1‐alpha and carbonic anhydrase‐9 overexpression in non‐small cell lung cancer

Charles C Wykoff, Adrian L Harris, A. Harris, 2003, The Journal of pathology.

Prognostic S ignificance o f a N ovel H ypoxia-Regulate d Marker, C arbonic A nhydrase I X, i n I nvasive B reast Carcinoma

A. Harris, P. Watson, C. Wykoff, 2001 .

The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer

A. Harris, P. Watson, R. Poulsom, 2002, British Journal of Cancer.

Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast.

W. Sly, A. Harris, P. Watson, 2001, The American journal of pathology.

Analysis of gene expression in ductal carcinoma in situ of the breast.

A. Harris, L. Murphy, P. Watson, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Quantitative Comparison of Fundus Images by Two Ultra-Wide Field Fundus Cameras.

D. Diloreto, C. Wykoff, M. Chung, 2020, Ophthalmology. Retina.

Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma

P H Watson, W. Sly, A. Harris, 2003, British Journal of Cancer.

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.

C. Wykoff, S. Fauser, J. Sahni, 2019, Ophthalmology.

Abicipar pegol for neovascular age-related macular degeneration

Christina Y. Weng, C. Wykoff, S. Hariprasad, 2020, Expert opinion on biological therapy.

C. Wykoff, 2019, Geriatric Ophthalmology.

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.

Philip J Rosenfeld, Charles C Wykoff, Bernhard H F Weber, 2020, Ophthalmology.

Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.

A. Harris, C. Wykoff, J. Pastorek, 2001, Cancer research.

Genetic Analysis of the Role of the Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-inducible Factor (HIF) in Regulating HIF Transcriptional Target Genes*

C. Wykoff, P. Ratcliffe, H. Turley, 2004, Journal of Biological Chemistry.

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene

C. Sotiriou, A. Harris, C. Wykoff, 2004, British Journal of Cancer.

Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.

A. Harris, C. Wykoff, J. Pastorek, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: a Macula Society Collaborative Study.

Alexis K. Warren, Rishi P. Singh, B. Lujan, 2021, Ophthalmology. Retina.

The effect of pregnancy on diabetic retinopathy

C. Wykoff, David M. Brown, 2012 .

Diagnostic and Therapeutic Challenges.

C. Wykoff, M. Radwan, F. Burgess, 2018, Retina.

PROGRESSIVE RETINAL NONPERFUSION IN ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION

C. Wykoff, David M. Brown, T. P. Wong, 2015, Retina.

RANIBIZUMAB IN PREPROLIFERATIVE (ISCHEMIC) CENTRAL RETINAL VEIN OCCLUSION: The Rubeosis Anti-VEGF (RAVE) Trial

C. Wykoff, David M. Brown, T. P. Wong, 2014, Retina.

THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A REVIEW [67/135 characters].

Rishi P. Singh, C. Wykoff, T. Lai, 2020, Retina.

Simultaneous presentation of retinoblastoma and morning glory disk anomaly.

C. Wykoff, S. Dubovy, T. Murray, 2009, Retinal cases & brief reports.

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

C. Wykoff, G. Jaffe, J. Heier, 2023, Eye.

Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration

C. Wykoff, Hannah J. Yu, 2021, BioDrugs.

Protecting Vision in Patients With Diabetes With Ultra-Widefield Imaging: A Review of Current Literature.

Christina Y. Weng, Ajay E. Kuriyan, Rishi P. Singh, 2019, Ophthalmic surgery, lasers & imaging retina.

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

Rishi P. Singh, R. Shah, P. Campochiaro, 2022, The Lancet.

Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study.

E. Souied, C. Wykoff, A. Lotery, 2020, Ophthalmology.

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy

C. Wykoff, G. Yancopoulos, D. Weinreich, 2021, JAMA ophthalmology.

Suprachoroidal Triamcinolone Acetonide for Diabetic Macular Edema: The HULK Trial.

S. Sadda, C. Wykoff, G. Noronha, 2018, Ophthalmology. Retina.

Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study.

P. Campochiaro, C. Wykoff, G. Noronha, 2017, Ophthalmology. Retina.

Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial.

S. Sadda, C. Wykoff, A. Mousa, 2017, Ophthalmology.

Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?

M. Bhandari, S. Sivaprasad, S. Garg, 2022, Eye.

Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders

C. Wykoff, T. Ciulla, C. Wan, 2020, Translational vision science & technology.

Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective Trials.

P. Kaiser, S. Sadda, C. Wykoff, 2020, Ophthalmology. Retina.

Noncompliance in Prospective Retina Clinical Trials: Analysis of factors predicting loss to follow up.

C. Wykoff, David M. Brown, Brenda Zhou, 2020, American journal of ophthalmology.

Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.

Beau B. Bruce, B. Bruce, C. Wykoff, 2017, Ophthalmology.

Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.

P. Campochiaro, C. Wykoff, J. Cunha-Vaz, 2017, Ophthalmology.

New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium

C. Puliafito, C. Wykoff, 2020, International Journal of Retina and Vitreous.

Real-Time Diabetic Retinopathy Severity Score Level versus Ultra-Widefield Leakage Index-Guided Management of Diabetic Retinopathy: Two-Year Outcomes from the Randomized PRIME Trial

Jamie L. Reese, C. Wykoff, S. Srivastava, 2021, Journal of personalized medicine.

Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.

C. Regillo, C. Wykoff, B. Berger, 2023, Ophthalmology.

When and How to Incorporate Steroids for Persistent Diabetic Macular Edema: A Discussion of Real-World Treatment Optimization Strategies.

Christina Y. Weng, C. Wykoff, D. Dhoot, 2018, Ophthalmic surgery, lasers & imaging retina.

Office-based intravitreal injection of expansile gas for management of macular hole in previously vitrectomized eyes

C. Wykoff, C. R. Henry, S. Lampen, 2019, American Journal of Ophthalmology Case Reports.

Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy.

D. Roth, C. Wykoff, Z. Haskova, 2018, Ophthalmology. Retina.

Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial

S. Sadda, C. Wykoff, M. Ip, 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

Refill-Exchange Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Trial Experience.

C. Wykoff, Natalia F. Callaway, G. Barteselli, 2022, Ophthalmic surgery, lasers & imaging retina.

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration

C. Wykoff, J. Brill, L. Greene, 2018, Journal of managed care & specialty pharmacy.

COMPARISON OF SPECTRAL-DOMAIN AND TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION ACTIVITY

C. Wykoff, David M. Brown, J. Major, 2014, Retina.

Diffuse neonatal hemangiomatosis presenting as bilateral iris hemangiomas in an infant.

C. Wykoff, T. Murray, Jacqueline L. Tutiven, 2009, Retinal cases & brief reports.

Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study.

C. Wykoff, R. Vitti, Namrata Saroj, 2019, Ophthalmology.

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.

Katherine E. Talcott, Jamie L. Reese, C. Wykoff, 2019, Ophthalmology. Retina.

Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.

C. Wykoff, David M. Brown, R. Y. Kim, 2018, Ophthalmology.

Valsalva Retinopathy After Yoga in a Patient With No Clear Predisposing Condition

C. Wykoff, K. Fan, Stephanie Trejo Corona, 2023, Journal of VitreoRetinal Diseases.

Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c: Analyses from VISTA and VIVID.

Rishi P. Singh, M. Larsen, C. Wykoff, 2017, Ophthalmology. Retina.

Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.

K. Ghasemi Falavarjani, S. Sadda, C. Wykoff, 2018, Investigative ophthalmology & visual science.

Anti-vascular endothelial growth factor therapy and retinal non-perfusion in diabetic retinopathy: A meta-analysis of randomised trials.

P. Kaiser, S. Sivaprasad, C. Wykoff, 2023, Acta ophthalmologica.

Favorable Anti-VEGF Crunch Syndrome: Nonsurgical Relief of Vitreoretinal Traction in Eyes With Proliferative Diabetic Retinopathy and Tractional Retinal Detachment.

H. Flynn, C. Wykoff, Irene T Lee, 2022, Ophthalmic surgery, lasers & imaging retina.

Evidence-Based Guidelines for Management of Diabetic Macular Edema

C. Regillo, H. Flynn, C. Wykoff, 2019, Journal of VitreoRetinal Diseases.

DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema.

C. Wykoff, S. Hariprasad, 2016, Ophthalmic surgery, lasers & imaging retina.

Positive Visual Phenomena Following Implantation of the Argus II Retinal Prosthesis.

M. Humayun, C. Wykoff, H. Nazari, 2017, Ophthalmic surgery, lasers & imaging retina.

Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy

C. Wykoff, F. Lum, Q. Nguyen, 2021, Diabetes Care.

CHOROIDAL NEOVASCULARIZATION SECONDARY TO ALEXANDRITE LASER EXPOSURE.

C. Wykoff, David M. Brown, R. Fish, 2016, Retinal cases & brief reports.

Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials.

C. Regillo, M. Elman, C. Wykoff, 2016, Ophthalmology.

Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: TREX-AMD 1-Year Results.

Charles C Wykoff, SriniVas R Sadda, Nizar Saleh Abdelfattah, 2015, Ophthalmology.

Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.

B. Bruce, C. Wykoff, H. Tabandeh, 2019, American journal of ophthalmology.

Randomized Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: 2-Year Results of the TREX-AMD Study.

S. Sadda, C. Wykoff, David M. Brown, 2017, Ophthalmology. Retina.

Automated vessel density detection in fluorescein angiography images correlates with vision in proliferative diabetic retinopathy

Mohammad H. Bawany, Ajay E. Kuriyan, Ajay E Kuriyan, 2020, PloS one.

The Intersection of Diabetes Mellitus and Cataract Surgery: Current State of Management.

C. Wykoff, N. Steinle, S. Lampen, 2017, Ophthalmology. Retina.

Preoperative evaluation for patients with choroidal/ciliary body melanomas: what is necessary?

A. Markoe, C. Wykoff, L. Feun, 2011, American journal of ophthalmology.

Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results

C. Wykoff, T. Hassan, M. Attar, 2023, Clinical ophthalmology.

EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Rishi P. Singh, C. Wykoff, F. Holz, 2021, Retina.

Home Monitoring of Age-Related Macular Degeneration

C. Wykoff, V. Sheth, Daniel F. Kiernan, 2020, Ophthalmology Retina.

Early Residual Fluid-free Status and Long-term BCVA outcomes: A Treatment Agnostic, Post-hoc Analysis of Pooled HAWK and HARRIER Data.

C. Wykoff, C. Eandi, A. Chang, 2021, American journal of ophthalmology.

One-Year Real-World Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large US Cohort in the IRIS® Registry.

C. Wykoff, M. Zarbin, M. Ip, 2023, Ophthalmology.

Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab.

C. Wykoff, M. Zarbin, M. Ip, 2023, Ophthalmology.

INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PHARMACEUTICAL UTILIZATION AND FINANCIAL IMPACT IN A VALUE-BASED CARE PROGRAM

C. Wykoff, A. G. Lee, C. Daruwalla, 2022, Retina.

Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial.

S. Sadda, C. Wykoff, A. Hariri, 2018, American journal of ophthalmology.

Aflibercept for pigment epithelial detachment for previously treated neovascular age-related macular degeneration.

C. Wykoff, David M. Brown, J. Major, 2015, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)

C. Wykoff, David M. Brown, Daniel E. Croft, 2014, British Journal of Ophthalmology.

SAVE (Super-dose anti-VEGF) trial: 2.0 mg ranibizumab for recalcitrant neovascular age-related macular degeneration: 1-year results.

C. Wykoff, David M. Brown, T. P. Wong, 2013, Ophthalmic surgery, lasers & imaging retina.

Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and Enrollment

Sagar B. Patel, C. Wykoff, David M. Brown, 2023, Journal of Personalized Medicine.

The 5 min meta-analysis: understanding how to read and interpret a forest plot

Rishi P. Singh, M. Bhandari, S. Sivaprasad, 2022, Eye.

Retinal Nonperfusion (RNP) Extent and its Relationship with Visual, Anatomic and Disease State Outcomes Among Eyes Treated for Diabetic Macular Edema (DME)

C. Wykoff, 2020 .

YOSEMITE and RHINE

Rishi P. Singh, N. Eter, P. Ruamviboonsuk, 2021, Ophthalmology Science.

Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in patients with Diabetic Macular Edema.

S. Sadda, C. Wykoff, Jano van Hemert, 2019, American journal of ophthalmology.

GRANULAR HYPERREFLECTIVE SPECKS BY SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS SIGNS OF WEST NILE VIRUS INFECTION: THE STARDUST SIGN.

C. Wykoff, David M. Brown, Rui Wang, 2015, Retinal cases & brief reports.

USE OF OPTICAL COHERENCE TOMOGRAPHY IN DETECTING RETINAL TEARS IN ACUTE, SYMPTOMATIC POSTERIOR VITREOUS DETACHMENT

Sagar B. Patel, C. Wykoff, David M. Brown, 2022, Retina.

A Novel Deep Learning Pipeline for Retinal Vessel Detection In Fluorescein Angiography

Gaurav Sharma, Li Ding, Mohammad H. Bawany, 2019, IEEE Transactions on Image Processing.

American Society of Retina Specialists Clinical Practice Guidelines: Management of Nonproliferative and Proliferative Diabetic Retinopathy Without Diabetic Macular Edema

Judy E. Kim, C. Wykoff, L. Kim, 2020, Journal of vitreoretinal diseases.

Loss to Follow-Up Among Patients with Proliferative Diabetic Retinopathy in Clinical Practice.

C. Wykoff, Ankoor R. Shah, R. Fish, 2020, American journal of ophthalmology.

Gene Therapy for Retinal Diseases Is Within Sight

C. Wykoff, 2014 .

Looking ahead in retinal disease management: highlights of the 2019 angiogenesis, exudation and degeneration symposium

C. Puliafito, C. Wykoff, 2019, International Journal of Retina and Vitreous.

Real-Time Photographic and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.

Justis P. Ehlers, Jamie L. Reese, C. Wykoff, 2021, American journal of ophthalmology.

Effect of Aflibercept on Diabetic Retinopathy Severity and Visual Function in the RECOVERY Study for Proliferative Diabetic Retinopathy.

S. Sadda, C. Wykoff, M. Nittala, 2020, Ophthalmology. Retina.

Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography.

Jano van Hemert, Michael Verhoek, Charles C Wykoff, 2014, Ophthalmic surgery, lasers & imaging retina.

Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial.

S. Sadda, C. Wykoff, David M. Brown, 2017, Ophthalmology.

Questionnaire to Assess Life Impact of Treatment by Intravitreal Injections (QUALITII): Development of a patient-reported measure to assess treatment burden of repeat intravitreal injections

C. Regillo, C. Wykoff, Namrata Saroj, 2021, BMJ Open Ophthalmology.

Management and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records.

C. Wykoff, S. Kiss, A. Almony, 2020, Ophthalmology.

Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System.

C. Wykoff, S. Hariprasad, Brenda Zhou, 2018, Ophthalmic surgery, lasers & imaging retina.

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept

Justis P. Ehlers, Jamie L. Reese, S. Sadda, 2021, Journal of personalized medicine.

Longitudinal analysis of aqueous humour cytokine expression and OCT-based imaging biomarkers in retinal vein occlusions treated with anti-vascular endothelial growth factor therapy in the IMAGINE study

Joseph R. Abraham, Jamie L. Reese, C. Wykoff, 2022, Eye.

Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context

C. Wykoff, D. Do, H. Moini, 2022, BMJ Open Ophthalmology.

Longitudinal panretinal microaneurysm dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study

Katherine E. Talcott, Justis P. Ehlers, Jamie L. Reese, 2020, British Journal of Ophthalmology.

RETINAL LEAKAGE INDEX DYNAMICS ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY IN EYES TREATED WITH INTRAVITREAL AFLIBERCEPT FOR PROLIFERATIVE DIABETIC RETINOPATHY IN THE RECOVERY STUDY.

Katherine E. Talcott, Jamie L. Reese, C. Wykoff, 2020, Retina.

Impact of intravitreal pharmacotherapies including antivascular endothelial growth factor and corticosteroid agents on diabetic retinopathy

C. Wykoff, 2017, Current opinion in ophthalmology.

Diabetic Retinopathy and Its Management

C. Wykoff, 2019, Geriatric Ophthalmology.

Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.

Jennifer K. Sun, N. Bressler, C. Wykoff, 2020, JAMA ophthalmology.

Telescope Implant—Changing Visual Expectations and Evolving the Standard of Care for End-stage Age-related Macular Degeneration Patients

C. Wykoff, 2015 .

Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.

Rishi P. Singh, P. Rosenfeld, J. Slakter, 2021, Ophthalmology.

Analysis of Gene Expression in Ductal Carcinoma in Situ of the Breast 1

A. Harris, L. Murphy, P. Watson, 2002 .

RETINAL VASCULAR BED AREA IN EYES WITH RETINAL VEIN OCCLUSION ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY

C. Wykoff, A. Fleming, Jano van Hemert, 2022, Retina.

Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy

Jennifer K. Sun, Paolo S. Silva, L. Aiello, 2019, JAMA ophthalmology.

Identification of factors to increase efficacy of telemedicine screening for diabetic retinopathy in endocrinology practices using the Intelligent Retinal Imaging System (IRIS) platform.

C. Wykoff, Ankoor R. Shah, W. Ou, 2018, Diabetes research and clinical practice.

Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapy

S. Sadda, C. Wykoff, D. Sarraf, 2021, British Journal of Ophthalmology.

Five-Year Outcomes of Surgically Treated Symptomatic Epiretinal Membranes With and Without Internal Limiting Membrane Peeling.

C. Wykoff, Ankoor R. Shah, Harris Sultan, 2018, Ophthalmic surgery, lasers & imaging retina.

Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial

R. Shah, P. Campochiaro, S. Gupta, 2023, Japanese Journal of Ophthalmology.

Optical Coherence Tomography Biomarkers for Conversion to Exudative Neovascular Age-related Macular Degeneration.

C. Wykoff, Kenneth M. Marion, S. Sadda, 2022, American journal of ophthalmology-glaucoma.

Patient-Reported Outcome Measure Usage in Guidelines Published by the American Academy of Ophthalmology - a Review.

S. Sivaprasad, C. Wykoff, R. Guymer, 2023, Ophthalmology.

Clinically Labeled Contrastive Learning for OCT Biomarker Classification

C. Wykoff, M. Prabhushankar, Stephanie Trejo Corona, 2023, IEEE Journal of Biomedical and Health Informatics.

Gradient-Based Severity Labeling for Biomarker Classification in Oct

C. Wykoff, M. Prabhushankar, Stephanie Trejo Corona, 2022, 2022 IEEE International Conference on Image Processing (ICIP).

Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment

C. Wykoff, N. Choudhry, S. Orr, 2023, BMJ open ophthalmology.

What makes a good survey?

M. Bhandari, S. Sivaprasad, S. Garg, 2023, Eye.

Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials

C. Wykoff, Karen W. Jeng-Miller, J. Hsu, 2023, Ophthalmology science.

Optical Coherence Tomography Risk Factors for Development of Atrophy in Eyes with Intermediate Age-related Macular Degeneration.

C. Wykoff, Kenneth M. Marion, S. Sadda, 2022, Ophthalmology. Retina.

BALATON and COMINO: Phase 3 Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale

Y. Liu, C. Wykoff, Z. Haskova, 2023, Ophthalmology Science.

Pseudohypopyon as a clinical manifestation in metastatic lung carcinoma.

C. Wykoff, S. Dubovy, T. Murray, 2012, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

Comment on "fundus autofluorescence and multiple evanescent white dot syndrome".

C. Wykoff, T. Albini, R. Sisk, 2009, Retina.

A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular age-related macular degeneration.

M. Buyse, J. Slakter, C. Wykoff, 2023, Ophthalmology.

RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

C. Wykoff, O. Oshagbemi, J. Heier, 2023, Retina.

Impact of Prefilled Syringes and Masking on Postintravitreal Injection Endophthalmitis

C. Wykoff, Sagar B Patel, Hannah J. Yu, 2023, Journal of vitreoretinal diseases.

Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.

B. Joondeph, J. Pearlman, C. Wykoff, 2023, JAMA ophthalmology.

Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad.

A. Cruess, C. Wykoff, S. Michels, 2016, American journal of ophthalmology.